https://alexberenson.substack.com/p/what-has-happened-to-journalism-volume
Before Covid hysteria and hatred for Donald Trump broke his brain, Adam Feuerstein was a pretty good reporter.
Feuerstein has covered Big Pharma for many years, since 2017 for an pharmaceutical and healthcare-focused Website called STAT. Among biotechnology investors, he’s widely read and sometimes feared. He has a long memory for the hyperbole (if not outright scams) that many biotech executives engage in as they struggle to develop new drugs.
So when Pfizer announced Dr. Scott Gottlieb – who had resigned as commissioner of the Food and Drug Administration just months earlier – would be joining its board, Feuerstein’s salty take was not surprising:—
These days, though, Feuerstein has a somewhat different attitude towards Gottlieb, as a reverential interview from September 2021 reveals. It’s full of hardball questions like:
You have this unique position now – you were in government, you’re no longer in government. You sit on many different seats of power and access. Do you ever think about going back in?
(However do you do it all, Dr. G? And how do you look so good in that suit?)—
The irony here could not be thicker, as you have probably already realized. Because Feuerstein’s joking prediction of three years ago has turned out to be right. In August the FDA approved the bivalent boosters from Pfizer based on data from eight mice.
Can’t make it up.
One might think the fact the federal government has essentially become a promotional partner of the mRNA vaccine companies would encourage drug industry and investigative reporters like Feuerstein to ask hard questions about the vaccines.
One would be wrong.